[HTML][HTML] Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
JA Alegría-Baños, JC Jiménez-López… - Journal of Ovarian …, 2021 - Springer
Background Ovarian cancer (OC) is considered the most lethal gynecological cancer, of
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
[PDF][PDF] Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
JA Alegría-Baños, JC Jiménez-López… - scholar.archive.org
Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in
advanced epithelial ovarian cancer Page 1 Page 1/21 Kinetics of HE4 and CA125 as prognosis …
advanced epithelial ovarian cancer Page 1 Page 1/21 Kinetics of HE4 and CA125 as prognosis …
Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
JA Alegría-Baños, JC Jiménez-López… - 2021 - academiccommons.columbia.edu
Background Ovarian cancer (OC) is considered the most lethal gynecological cancer, of
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
JA Alegría-Baños, JC Jiménez-López… - Journal of Ovarian …, 2021 - search.proquest.com
Background Ovarian cancer (OC) is considered the most lethal gynecological cancer, of
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
JA Alegría-Baños, JC Jiménez-López… - Journal of Ovarian …, 2021 - europepmc.org
Background Ovarian cancer (OC) is considered the most lethal gynecological cancer, of
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
[HTML][HTML] Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
JA Alegría-Baños… - Journal of …, 2021 - ovarianresearch.biomedcentral.com
Ovarian cancer (OC) is considered the most lethal gynecological cancer, of which more than
65% cases are diagnosed in advanced stages, requiring platinum-based neoadjuvant …
65% cases are diagnosed in advanced stages, requiring platinum-based neoadjuvant …
Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
JA Alegría-Baños, JC Jiménez-López… - 2021 - researchsquare.com
Background Ovarian cancer (OC) is considered the most lethal gynecological cancer, of
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
JA Alegría-Baños, JC Jiménez-López… - Journal of Ovarian …, 2021 - search.ebscohost.com
Background: Ovarian cancer (OC) is considered the most lethal gynecological cancer, of
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
JA Alegría-Baéos, JC Jiménez-López… - Journal of Ovarian …, 2021 - go.gale.com
Background Ovarian cancer (OC) is considered the most lethal gynecological cancer, of
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
[HTML][HTML] Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
JA Alegría-Baños, JC Jiménez-López… - Journal of Ovarian …, 2021 - ncbi.nlm.nih.gov
Background Ovarian cancer (OC) is considered the most lethal gynecological cancer, of
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …
which more than 65% cases are diagnosed in advanced stages, requiring platinum-based …